The spread of coronavirus disease 2019 (COVID-19) continues to grow exponentially in most countries, posing an unprecedented burden on the healthcare sector and the world economy. Previous respiratory virus outbreaks, such as severe acute respiratory syndrome (SARS), pandemic H1N1 and Middle East respiratory syndrome (MERS), have provided significant insights into preparation and provision of intensive care support including extracorporeal membrane oxygenation (ECMO). Many patients have already been supported with ECMO during the current COVID-19 pandemic, and it is likely that many more may receive ECMO support, although, at this point, the role of ECMO in COVID-19-related cardiopulmonary failure is unclear. Here, we review the experience with the use of ECMO in the past respiratory virus outbreaks and discuss potential role for ECMO in COVID-19.
Bibliographical noteFunding Information:
HJC acknowledges the support of a grant NRF-2018R1D1A1A02085975 from the National Research Foundation of Korea and a grant BCRI18028 from the Chonnam National University Hospital Biomedical Research Institute.
© 2020 The Author(s).
- Coronavirus disease-2019 (COVID-19)
- Extracorporeal membrane oxygenation (ECMO)
- Middle East respiratory syndrome (MERS)
- Pandemic H1N1
- Severe acute respiratory syndrome (SARS)
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine